244 related articles for article (PubMed ID: 31332230)
1. Three-dimensional HepaRG spheroids as a liver model to study human genotoxicity in vitro with the single cell gel electrophoresis assay.
Mandon M; Huet S; Dubreil E; Fessard V; Le Hégarat L
Sci Rep; 2019 Jul; 9(1):10548. PubMed ID: 31332230
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the genotoxic potential of indirect chemical mutagens in HepaRG cells by the comet and the cytokinesis-block micronucleus assays.
Le Hegarat L; Dumont J; Josse R; Huet S; Lanceleur R; Mourot A; Poul JM; Guguen-Guillouzo C; Guillouzo A; Fessard V
Mutagenesis; 2010 Nov; 25(6):555-60. PubMed ID: 20675360
[TBL] [Abstract][Full Text] [Related]
3. Development of in vitro 3D cell model from hepatocellular carcinoma (HepG2) cell line and its application for genotoxicity testing.
Štampar M; Tomc J; Filipič M; Žegura B
Arch Toxicol; 2019 Nov; 93(11):3321-3333. PubMed ID: 31542801
[TBL] [Abstract][Full Text] [Related]
4. High-throughput micronucleus assay using three-dimensional HepaRG spheroids for in vitro genotoxicity testing.
Seo JE; Li X; Le Y; Mei N; Zhou T; Guo X
Arch Toxicol; 2023 Apr; 97(4):1163-1175. PubMed ID: 36847820
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the mutagenicity of N-nitrosodimethylamine in 2D and 3D HepaRG cell cultures using error-corrected next generation sequencing.
Seo JE; Le Y; Revollo J; Miranda-Colon J; Xu H; McKinzie P; Mei N; Chen T; Heflich RH; Zhou T; Robison T; Bonzo JA; Guo X
Arch Toxicol; 2024 Jun; 98(6):1919-1935. PubMed ID: 38584193
[TBL] [Abstract][Full Text] [Related]
6. Towards better prediction of xenobiotic genotoxicity: CometChip technology coupled with a 3D model of HepaRG human liver cells.
Barranger A; Le Hégarat L
Arch Toxicol; 2022 Jul; 96(7):2087-2095. PubMed ID: 35419617
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an in vitro three-dimensional HepaRG spheroid model for genotoxicity testing using the high-throughput CometChip platform.
Seo JE; He X; Muskhelishvili L; Malhi P; Mei N; Manjanatha M; Bryant M; Zhou T; Robison T; Guo X
ALTEX; 2022; 39(4):583-604. PubMed ID: 35791290
[TBL] [Abstract][Full Text] [Related]
8. Quantitative comparison of in vitro genotoxicity between metabolically competent HepaRG cells and HepG2 cells using the high-throughput high-content CometChip assay.
Seo JE; Tryndyak V; Wu Q; Dreval K; Pogribny I; Bryant M; Zhou T; Robison TW; Mei N; Guo X
Arch Toxicol; 2019 May; 93(5):1433-1448. PubMed ID: 30788552
[TBL] [Abstract][Full Text] [Related]
9. Application of HepG2/C3A liver spheroids as a model system for genotoxicity studies.
Coltman NJ; Coke BA; Chatzi K; Shepherd EL; Lalor PF; Schulz-Utermoehl T; Hodges NJ
Toxicol Lett; 2021 Jul; 345():34-45. PubMed ID: 33865918
[TBL] [Abstract][Full Text] [Related]
10. Performance of comet and micronucleus assays in metabolic competent HepaRG cells to predict in vivo genotoxicity.
Le Hégarat L; Mourot A; Huet S; Vasseur L; Camus S; Chesné C; Fessard V
Toxicol Sci; 2014 Apr; 138(2):300-9. PubMed ID: 24431211
[TBL] [Abstract][Full Text] [Related]
11. Genotoxicity assessment of eight nitrosamines using 2D and 3D HepaRG cell models.
Seo JE; Yu JZ; Xu H; Li X; Atrakchi AH; McGovern TJ; Bruno KLD; Mei N; Heflich RH; Guo X
Arch Toxicol; 2023 Oct; 97(10):2785-2798. PubMed ID: 37486449
[TBL] [Abstract][Full Text] [Related]
12. Liver-on-chip model and application in predictive genotoxicity and mutagenicity of drugs.
Kopp B; Khawam A; Di Perna K; Lenart D; Vinette M; Silva R; Zanoni TB; Rore C; Guenigault G; Richardson E; Kostrzewski T; Boswell A; Van P; Valentine Iii C; Salk J; Hamel A
Mutat Res Genet Toxicol Environ Mutagen; 2024; 896():503762. PubMed ID: 38821675
[TBL] [Abstract][Full Text] [Related]
13. Use of human derived liver cells for the detection of genotoxins in comet assays.
Mišík M; Nersesyan A; Ropek N; Huber WW; Haslinger E; Knasmueller S
Mutat Res Genet Toxicol Environ Mutagen; 2019 Sep; 845():402995. PubMed ID: 31561885
[TBL] [Abstract][Full Text] [Related]
14. Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations.
Conway GE; Shah UK; Llewellyn S; Cervena T; Evans SJ; Al Ali AS; Jenkins GJ; Clift MJD; Doak SH
Mutagenesis; 2020 Sep; 35(4):319-330. PubMed ID: 32780103
[TBL] [Abstract][Full Text] [Related]
15. Use of HepG2 cell line for direct or indirect mutagens screening: comparative investigation between comet and micronucleus assays.
Valentin-Severin I; Le Hegarat L; Lhuguenot JC; Le Bon AM; Chagnon MC
Mutat Res; 2003 Apr; 536(1-2):79-90. PubMed ID: 12694748
[TBL] [Abstract][Full Text] [Related]
16. An Automated Multiplexed Hepatotoxicity and CYP Induction Assay Using HepaRG Cells in 2D and 3D.
Ott LM; Ramachandran K; Stehno-Bittel L
SLAS Discov; 2017 Jun; 22(5):614-625. PubMed ID: 28346810
[TBL] [Abstract][Full Text] [Related]
17. HepaRG culture in tethered spheroids as an in vitro three-dimensional model for drug safety screening.
Wang Z; Luo X; Anene-Nzelu C; Yu Y; Hong X; Singh NH; Xia L; Liu S; Yu H
J Appl Toxicol; 2015 Aug; 35(8):909-17. PubMed ID: 25512232
[TBL] [Abstract][Full Text] [Related]
18. DMSO-free highly differentiated HepaRG spheroids for chronic toxicity, liver functions and genotoxicity studies.
Rose S; Cuvellier M; Ezan F; Carteret J; Bruyère A; Legagneux V; Nesslany F; Baffet G; Langouët S
Arch Toxicol; 2022 Jan; 96(1):243-258. PubMed ID: 34762139
[TBL] [Abstract][Full Text] [Related]
19. The comet assay applied to HepG2 liver spheroids.
Elje E; Hesler M; Rundén-Pran E; Mann P; Mariussen E; Wagner S; Dusinska M; Kohl Y
Mutat Res Genet Toxicol Environ Mutagen; 2019 Sep; 845():403033. PubMed ID: 31561895
[TBL] [Abstract][Full Text] [Related]
20. Performance of high-throughput CometChip assay using primary human hepatocytes: a comparison of DNA damage responses with in vitro human hepatoma cell lines.
Seo JE; Wu Q; Bryant M; Ren L; Shi Q; Robison TW; Mei N; Manjanatha MG; Guo X
Arch Toxicol; 2020 Jun; 94(6):2207-2224. PubMed ID: 32318794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
